MERCHAVIA Nervio investment agreement signed, will invest up to NIS 650,000 against 6% in Nervio, an option for additional investment Post published:30/12/2020
CARDIACSENSE Cardiacsense (about 5.67%) – Estimated deadlines for receiving CE and FDA approvals for the medical watch Post published:09/12/2020
TRAINPAIN TrainPain (approximately 5.69%) – The trial results of the treatment using the digital platform for people suffering from fibromyalgia syndrome in Belgium Post published:09/12/2020
CARDIACSENSE Cardiacsense (about 5.67%) began an experiment to prove the effectiveness of the smartwatch it developed in measuring continuous breathing rate Post published:26/11/2020
MERCHAVIA The Memorandum of Understanding does not require an investment of up to NIS 650,000 in Nervio against the allotment of shares Post published:26/11/2020
MERCHAVIA The memorandum of understanding does not require an investment of up to $ 350m in Okon Medical as part of a $ 1.5m round of funding Post published:27/10/2020
pdf1 Ora Smart (approximately 1.93%), has signed a distribution agreement for the sale of its products in China Post published:18/10/2020
